Replies to post #202 on Claritus Pharmaceuticals Inc. (CLAZF)

[djmurdock]

I agree, the only slightly negative thing is cash on hand and further financing. But that's with every small bio start up. The market cap is so low for them already being in phase 2 trials.

I'm buying left and right at these prices. Aphria bought a lot at .45, so these prices are a steal IMO

[djmurdock]

I keep averaging down but this is getting ridiculous